BillionToOne, Inc. (NasdaqGS: BLLN)
Health Care · Health Care Providers & Services · US
$94.36
-3.80% today · -10.0% 1Y
BillionToOne, Inc. (NasdaqGS: BLLN) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $4.63B and employs 713 people.
Over the last twelve months the share price has lost 10.0%, trading between 61.96 and 150.44.
Tweenvest scores BillionToOne, Inc. across four factors: quality 66/100, value 14/100. Its strongest factor is quality.
BLLN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.63B
- Revenue (TTM)
- $397.41M
- P/E
- 127.55
- EPS
- 0.77
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $150.44
- 52-week low
- $61.96
- Avg volume (3M)
- —
- Shares outstanding
- 47.19M
- Employees
- 713
- Next earnings
- —
About BillionToOne, Inc.
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
- ISIN
- US0901681058
- Founded
- 2016
- Listed since
- Nov 6, 2025
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Galenica AGSWX: GALE | $5.11B | CHF85.25 | +0.06% |
| LifeStance Health Group, Inc.NasdaqGS: LFST | $4.75B | $12.46 | +0.28% |
| Concentra Group Holdings Parent, Inc.NYSE: CON | $4.74B | $37.55 | +0.97% |
| Option Care Health, Inc.NasdaqGS: OPCH | $4.65B | $31.11 | +0.13% |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company LimitedSHSE: 600332 | $4.56B | CN¥19.97 | +1.27% |
| Bumrungrad Hospital Public Company LimitedSET: BH | $4.45B | ฿188.00 | -0.27% |
| Chartwell Retirement ResidencesTSX: CSH.UN | $4.45B | CA$19.35 | -3.25% |
| Medicover AB (publ)OM: MCOV B | $4.00B | Skr267.50 | +1.52% |
Figures last refreshed Oct 11, 2026.